Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
CDT Equity Inc. issued 3,685,815 pre-funded warrants of warrant to Corvus Capital Limited.
- Security
- warrant
- Shares
- 3,685,815 pre-funded warrants
- Purchaser
- Corvus Capital Limited
Exact text from the filing
3,685,815 pre-funded warrants (the “Pre-Funded Warrants”) to purchase shares of Common Stock
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
CDT Equity Inc. issued 224,800 shares of common stock of common stock to Corvus Capital Limited for $7,000,000 that was satisfied through the issuance.
- Security
- common stock
- Shares
- 224,800 shares of common stock
- Purchaser
- Corvus Capital Limited
- Consideration
- $7,000,000 that was satisfied through the issuance
Exact text from the filing
CPL, including the potential liability associated with the litigation, to Corvus, a wholly-owned subsidiary of the Company’s Chief Executive Officer for a settlement amount of $7,000,000 that was satisfied through the issuance of the CDT Shares and Pre-Funded Warrants. Prior to the execution of the Agreement, CPL transferred its shareholding in its wholly-owned
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CDT Equity Inc. entered into Sale and Purchase Agreement with Corvus Capital Limited valued at settlement amount of $7,000,000 (effective 2025-12-08).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Corvus Capital Limited
- Value
- settlement amount of $7,000,000
- Effective
- 2025-12-08
Exact text from the filing
On December 8, 2025, CDT Equity Inc. (the “Company”) and Corvus Capital Limited (“Corvus”) entered into a Sale and Purchase Agreement (the “Agreement”) for the issuance of all of the outstanding shares of Conduit Pharmaceuticals Limited (“CPL”) held of record by the Company
View on SEC.gov